Donna Best

Part of Convatec Group Plc, Triad Life Sciences, Inc. is a biotech company based in Memphis, TN. The company is focused on developing and commercializing innovative, efficacious and affordable biomaterials for treating complex surgical and chronic wounds. Triad recently received FDA clearance to market Innovamatrix™, a next-generation extracellular matrix (ECM) wound care device. The company was founded in 2017 by Russell I. Olsen, who has been the CEO since then. Triad Life Sciences was acquired by Convatec Group Plc on March 14, 2022 for $450 million.

Part of Convatec Group Plc, Triad Life Sciences, Inc. is a biotech company based in Memphis, TN. The company is focused on developing and commercializing innovative, efficacious and affordable biomaterials for treating complex surgical and chronic wounds. Triad recently received FDA clearance to market Innovamatrix™, a next-generation extracellular matrix (ECM) wound care device. The company was founded in 2017 by Russell I. Olsen, who has been the CEO since then. Triad Life Sciences was acquired by Convatec Group Plc on March 14, 2022 for $450 million.

Part of Convatec Group Plc, Triad Life Sciences, Inc. is a biotech company based in Memphis, TN. The company is focused on developing and commercializing innovative, efficacious and affordable biomaterials for treating complex surgical and chronic wounds. Triad recently received FDA clearance to market Innovamatrix™, a next-generation extracellular matrix (ECM) wound care device. The company was founded in 2017 by Russell I. Olsen, who has been the CEO since then. Triad Life Sciences was acquired by Convatec Group Plc on March 14, 2022 for $450 million.

Part of Convatec Group Plc, Triad Life Sciences, Inc. is a biotech company based in Memphis, TN. The company is focused on developing and commercializing innovative, efficacious and affordable biomaterials for treating complex surgical and chronic wounds. Triad recently received FDA clearance to market Innovamatrix™, a next-generation extracellular matrix (ECM) wound care device. The company was founded in 2017 by Russell I. Olsen, who has been the CEO since then. Triad Life Sciences was acquired by Convatec Group Plc on March 14, 2022 for $450 million.